Table 1.
Spectrophotometric activity measurements of OXPHOS complexes.
| Skeletal muscle biopsy |
Fibroblast |
Myoblast |
||||
|---|---|---|---|---|---|---|
| Patient | Controls |
Patient | Controls |
Patient | Controls |
|
| (Mean ± SD, n = 25) | (Mean ± SD, n = 8) | (Mean ± SD, n = 4) | ||||
| Complex I | 0.093 | 0.104 | 0.195 | 0.197 | 0.139 | 0.151 |
| nmol NADH oxidised·min− 1·unit citrate synthase− 1 | ± 0.036 | ± 0.043 | ± 0.042 | |||
| Complex II | 0.110 | 0.145 | 0.187 | 0.219 | 0.165 | 0.126 |
| nmol DCPIP reduced·min− 1·unit citrate synthase− 1 | ± 0.047 | ± 0.067 | ± 0.013 | |||
| Complex IV | 0.318 | 1.124 | 1.081 | 1.083 | 0.601 | 1.084 |
| × 10− 3 K s− 1·unit citrate synthase− 1 | ± 0.511 | ± 0.186 | ± 0.105 | |||